FT News in Focus

What are the potential health benefits of gene editing?

Last year a Chinese scientist shocked the world by claiming that he had created the world’s first gene-edited babies. Anjana Ahuja talks to Robin Lovell-Badge, a developmental biologist and geneticist, about the controversy and about the potential for gene editing tools such as Crispr-Cas9 to revolutionise the treatment of genetic diseases.This podcast is supported by the European Federation of Pharmaceutical Industries and Associations. Read more in the FT Health series <a href="https://www.ft.com/RDHealth" target="_blank">Future of Research and Development </a> Contributors: Joshua Noble, weekend news editor. Anjana Ahuja, science columnist, and Robin Lovell-Badge, head of the Laboratory of Stem Cell Biology and Developmental Genetics at the <a href="https://www.crick.ac.uk/" target="_blank">Francis Crick Institute</a>. Producers: Ruth Lewis-Coste and Fiona Symon Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.

News features and analysis from Financial Times reporters around the world. FT News in Focus is produced by Fiona Symon. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.